期刊文献+

血液灌流、血液透析滤过治疗尿毒症性周围神经病的疗效观察 被引量:39

Effect investigation of hemoperfusion and hemodiafiltration in treating uremic peripheral neuropathy
下载PDF
导出
摘要 目的 探求治疗尿毒症性周围神经病的有效方法。方法 将 4 6例尿毒症性周围神经病行维持性血液透析患者随机分为血液灌流组和血液透析滤过组 ,血液灌流组在每周 2次常规血液透析 (HD)的同时 ,接受每周 1次HD +血液灌流 (HP)治疗 ;血液透析滤过组行每周 1次常规HD治疗 ,接受每周 2次血液透析滤过 (HDF)治疗 ,治疗前、治疗 1个月时分别观察两组患者周围神经病的临床症状、神经反射改善情况及正中神经、胫神经、腓总神经的感觉神经传导速度 (SCV) 3项指标。结果 两组经过 1个月的充分透析后 ,其临床症状、神经反射 ,正中神经、胫神经、腓总神经SCV均较治疗前有所改善 ,而血液灌流组SCV的改善程度显著优于血液透析滤过组 (P <0 .0 5 )。 Objective To investigate an effective treatment of uremic peripheral neuropathy. Methods Forty-six patients with uremic peripheral neuropathy were assigned randomly to hemoperfusion group and hemodiafiltration group. Patients of hemoperfusion group received regular hemodialysis 3 times a week and hemoperfusion once a week. The cases of hemodiafiltration group received regular hemodialysis once a week and hemodiafiltration 2 times a week. The clinical symptoms ,the nerve reflex and the sensory conduction velocity(SCV) of median nerve,tibial nerve and lateral popliteal nerve were observed in each group before and after treatment for 1 months.Result After treatment, the clinical symptoms and nerve reflex showed better than before in each group,but hemoperfusion group was significantly better than hemodiafiltation group (P<0.05).The SCV of median nerve, tibial nerve and lateral popliteal nerve was enhanced faster more in hemoperfusion group than hemodiafiltration group (P<0.05).Conclusion Hemoperfusion and hemodiafiltration are useful for uremic patients with peripheral neuropathy.
出处 《中国血液净化》 2004年第11期590-591,594,共3页 Chinese Journal of Blood Purification
关键词 血液透析滤过 血液灌流 血液透析 尿毒症性周围神经病 感觉神经传导速度 Hemoperfusion Hemodiafiltration Hemodialysis Uremic peripheral neuropathy Sensory conduction velocity
  • 相关文献

参考文献12

  • 1[1]Jurcic D,Bago J,Eljuga D.Features of uremic neuropathy in longterm dialysis.Coll Antropol,1998,22( 1 ):119-125 被引量:1
  • 2[2]Imam I,Salako BL,Akinola A.Peripheral neuropathy in Nigerian subjects with chronic renal failure.Niger J Med,2003,12(2):72-75 被引量:1
  • 3[3]Man NK,Cueille G,Zingraff J,et al.Uremic neurotoxin in the middle molecular weight range.Artif Organs,1980,4(2):116-120 被引量:1
  • 4[4]Dukanovic L.Middle molecular weight substances and uremic polyneuropathy.Acta Med Iugosl,1990,44(2):117-128 被引量:1
  • 5[5]Avram MM,Feinfeld DA,Huatuco AH.Search for the uremic toxin.Decreased motor-nerve conduction velocity and elevated parathyroid hormone in uremia.N Engl J Med,1978,298(18):1000-1003 被引量:1
  • 6[6]Aiello I,Serra G,Gilli P,et al.Uremic neuropathy:correlations between electroneurographic parameters and serum levels of parathyroid hormone and aluminum.Eur Neurol,1982,21 (6):396-400 被引量:1
  • 7[7]Barats MS,Gonick HC,Rothenberg S,et al.Severe lead-induced peripheral neuropathy in a dialysis patient.Am J Kidney Dis,2000,35(5):963-968 被引量:1
  • 8[8]Cisari C,Gasco P,Calabrese G,et al.Serum magnesium and nerve conduction velocity in uraemic patients on chronic haemodialysis.Magnes Res,1989,2(4):267-269 被引量:1
  • 9[9]Egan JD,Wells IC.Transketolase inhibition and uremic peripheral sensory neuropathy.J Neurol Sci,1979,41(3):379-95 被引量:1
  • 10[10]Kuriyama M,Mizuma A,Yokomine R,et al.Erythrocyte transketolase activity in uremia.Clin Chim Acta,1980,8,108(2):169-177 被引量:1

同被引文献202

引证文献39

二级引证文献217

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部